Clinical trials
Phase 2/3 Hypertension trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2019 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| First Affiliated Hospital of Harbin Medical University | 3 |
| All India Institute of Medical Sciences | 1 |
| C. T. Lamont Primary Care Research Centre | 1 |
| Hospital General de México Dr. Eduardo Liceaga | 1 |
| Jiangsu Province Hospital of Traditional Chinese Medicine | 1 |
| Shenzhen Ausa Pharmed Co.,Ltd | 1 |
| University of Monastir | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 9 |
| Diabetes Mellitus | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Dyslipidemias | 1 |
| Essential Hypertension | 1 |
| Heart Failure | 1 |
| Hyperhomocysteinemia | 1 |
| Insulin Resistance | 1 |
| Obesity | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.